J.C. Angulo

7.2k total citations · 1 hit paper
404 papers, 5.1k citations indexed

About

J.C. Angulo is a scholar working on Surgery, Urology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J.C. Angulo has authored 404 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Surgery, 158 papers in Urology and 137 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J.C. Angulo's work include Urological Disorders and Treatments (90 papers), Urinary Bladder and Prostate Research (84 papers) and Bladder and Urothelial Cancer Treatments (73 papers). J.C. Angulo is often cited by papers focused on Urological Disorders and Treatments (90 papers), Urinary Bladder and Prostate Research (84 papers) and Bladder and Urothelial Cancer Treatments (73 papers). J.C. Angulo collaborates with scholars based in Spain, United States and Portugal. J.C. Angulo's co-authors include José I. López, Manuel Sánchez‐Chapado, A. García-Tello, I. Arance, F. Ramón de Fata, Guillermo Andrés, J. Cambronero, David J. Grignon, Cristina Esquinas and H. Gimbernat and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

J.C. Angulo

380 papers receiving 4.9k citations

Hit Papers

Efficacy and Tolerability of Mirabegron, a β3-Adrenocepto... 2012 2026 2016 2021 2012 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial
    2012 329 citations J.C. Angulo, J. Cambronero et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.C. Angulo Spain 34 2.0k 1.8k 1.6k 1.4k 815 404 5.1k
Ziya Kırkalı Türkiye 40 1.5k 0.8× 2.9k 1.7× 3.5k 2.2× 974 0.7× 2.3k 2.8× 248 7.3k
Alessandro Sciarra Italy 41 1.3k 0.7× 954 0.5× 3.5k 2.2× 1.2k 0.9× 1.3k 1.6× 250 6.6k
Gabriella Nesi Italy 36 653 0.3× 1.6k 0.9× 1.5k 0.9× 541 0.4× 977 1.2× 259 4.6k
Young Deuk Choi South Korea 39 929 0.5× 2.0k 1.2× 3.3k 2.0× 931 0.7× 984 1.2× 362 6.0k
Christian Radmayr Austria 36 1.6k 0.8× 1.1k 0.6× 2.0k 1.2× 524 0.4× 1.7k 2.1× 149 5.6k
Thierry Lebrét France 39 2.0k 1.0× 3.8k 2.2× 1.8k 1.1× 574 0.4× 1.5k 1.8× 269 6.6k
J. Brantley Thrasher United States 44 950 0.5× 1.7k 0.9× 3.2k 2.0× 844 0.6× 1.8k 2.2× 134 6.6k
Gary D. Steinberg United States 52 2.0k 1.0× 5.4k 3.1× 3.2k 1.9× 805 0.6× 1.7k 2.1× 295 9.2k
Pierre Teillac France 34 1.8k 0.9× 878 0.5× 1.7k 1.0× 707 0.5× 425 0.5× 174 3.5k
Marco Moschini Italy 36 1.1k 0.5× 3.0k 1.7× 2.4k 1.5× 676 0.5× 455 0.6× 346 5.3k

Countries citing papers authored by J.C. Angulo

Since Specialization
Citations

This map shows the geographic impact of J.C. Angulo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.C. Angulo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.C. Angulo more than expected).

Fields of papers citing papers by J.C. Angulo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.C. Angulo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.C. Angulo. The network helps show where J.C. Angulo may publish in the future.

Co-authorship network of co-authors of J.C. Angulo

This figure shows the co-authorship network connecting the top 25 collaborators of J.C. Angulo. A scholar is included among the top collaborators of J.C. Angulo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.C. Angulo. J.C. Angulo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Angulo, J.C. & Miguel Vírseda Chamorro. (2024). The evaluation of urinary signs and symptoms in medieval medicine. SHILAP Revista de lepidopterología. 11. 100057–100057.
3.
Armesto, María, María Arestin, Manuel Manrique, et al.. (2024). Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients. International Journal of Molecular Sciences. 25(13). 6881–6881. 1 indexed citations
4.
Øyjord, Tove, Gunhild M. Mælandsmo, J.C. Angulo, et al.. (2024). Impact of B7-H3 expression on metastasis, immune exhaustion and JAK/STAT and PI3K/AKT pathways in clear cell renal cell carcinoma. OncoImmunology. 13(1). 2419686–2419686. 3 indexed citations
5.
Angulo, J.C., Gorka Larrinaga, Charles H. Lawrie, et al.. (2024). Predicting Survival of Metastatic Clear Cell Renal Cell Cancer Treated with VEGFR-TKI-Based Sequential Therapy. Cancers. 16(16). 2786–2786. 1 indexed citations
6.
Chamorro, Miguel Vírseda, et al.. (2023). Update on Adjustable Trans-Obturator Male System (ATOMS) for Male Incontinence after Prostate Cancer Surgery. Current Oncology. 30(4). 4153–4165. 4 indexed citations
7.
Sterling, Joshua, et al.. (2023). Complications after Prostate Cancer Treatment: Pathophysiology and Repair of Post-Radiation Urethral Stricture Disease. Journal of Clinical Medicine. 12(12). 3950–3950. 3 indexed citations
8.
López, José I., et al.. (2023). Distinct spatial landscapes in clear-cell renal cell carcinoma as revealed by whole transcriptome analysis. Immuno-Oncology Technology. 21. 100690–100690. 4 indexed citations
9.
Angulo, J.C., Alessandro Giammò, Carmen González Enguita, et al.. (2023). Results of Adjustable Trans-Obturator Male System in Patients with Prostate Cancer Treated with Prostatectomy and Radiotherapy: A Multicenter Study. Journal of Clinical Medicine. 12(14). 4721–4721. 2 indexed citations
10.
11.
12.
Larrinaga, Gorka, et al.. (2021). (Pro)renin Receptor Is a Novel Independent Prognostic Marker in Invasive Urothelial Carcinoma of the Bladder. Cancers. 13(22). 5642–5642. 1 indexed citations
13.
Manini, Claudia, J.C. Angulo, & José I. López. (2021). Mimickers of Urothelial Carcinoma and the Approach to Differential Diagnosis. SHILAP Revista de lepidopterología. 11(1). 110–123. 8 indexed citations
14.
Angulo, J.C., et al.. (2019). Complications of the urinary incontinence system ATOMS: description of risk factors and how to prevent these pitfalls. World Journal of Urology. 38(7). 1795–1803. 18 indexed citations
15.
Angulo, J.C., Reynaldo Gómez, Fernando P. Secín, et al.. (2018). [Current status of urological training in Latin America.]. PubMed. 71(1). 23–33. 4 indexed citations
16.
Kerrebroeck, Philip Van, François Haab, J.C. Angulo, et al.. (2013). Efficacy and Safety of Solifenacin Plus Tamsulosin OCAS in Men with Voiding and Storage Lower Urinary Tract Symptoms: Results from a Phase 2, Dose-finding Study (SATURN). European Urology. 64(3). 398–407. 50 indexed citations
17.
Angulo, J.C., et al.. (2012). Cistectomía radical laparoendoscópica con neovejiga íleal ortotópica a través de puerto único umbilical. Actas Urológicas Españolas. 36(9). 554–561. 13 indexed citations
18.
Khullar, Vikram, J. Cambronero, J.C. Angulo, et al.. (2012). Age-related efficacy of the selective ß3-adrenoceptor agonist mirabegron for the treatment of overactive bladder (OAB): pooled analysis of three prospective, randomised Phase III studies in patients aged >= 65 years. 8 indexed citations
19.
Νitti, Victor W., Sender Herschorn, Vikram Khullar, et al.. (2012). Efficacy of mirabegron in patients with overactive bladder (OAB): Pre-specified analysis of three randomised, double-blind, placebo-controlled, Phase III studies. Neurourology and Urodynamics. 4 indexed citations
20.
Angulo, J.C.. (2006). Vida y color. 82.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziya Kırkalı Breakdown of academic impact, for papers by Alessandro Sciarra Breakdown of academic impact, for papers by Gabriella Nesi Breakdown of academic impact, for papers by Young Deuk Choi Breakdown of academic impact, for papers by Christian Radmayr Breakdown of academic impact, for papers by Thierry Lebrét Breakdown of academic impact, for papers by J. Brantley Thrasher Breakdown of academic impact, for papers by Gary D. Steinberg Breakdown of academic impact, for papers by Pierre Teillac Breakdown of academic impact, for papers by Marco Moschini
Rankless by CCL
2026